U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
184201184201Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate CancerCompletedNo Results AvailableProstate Cancer|Erectile DysfunctionDrug: sildenafil citrate and questionaires|Drug: placebo tablets and questionaireshttps://ClinicalTrials.gov/show/NCT00142506
184202184202Effect of Affective Content on Drug Induced Amnesia of Episodic MemoryCompletedNo Results AvailableMemory Losses|Amnesia-Memory LossDrug: Propofol|Drug: Thiopental Sodium|Drug: Dexmedetomidine Hydrochloride|Drug: Midazolam Hydrochloride|Drug: placebohttps://ClinicalTrials.gov/show/NCT00142493
184203184203Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder CancerActive, not recruitingNo Results AvailableBiliary Tract Cancer|Gallbladder AdenocarcinomaDrug: Capecitabine|Drug: Oxaliplatin|Drug: Bevacizumab|Procedure: Radiation therapyhttps://ClinicalTrials.gov/show/NCT00142480
184204184204Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular CarcinomaCompletedNo Results AvailableHepatocellular CarcinomaDrug: Gemcitabine|Drug: Oxaliplatin|Drug: Bevacizumabhttps://ClinicalTrials.gov/show/NCT00142467
184205184205NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)CompletedNo Results AvailableMalignant MelanomaBiological: NY-ESO-1 protein|Drug: Imiquimodhttps://ClinicalTrials.gov/show/NCT00142454
184206184206Effect of Pulse Width on Scar Treatment Using a 595-Nm Pulsed Dye LaserCompletedNo Results AvailableKeloids|Hypertrophic ScarsDevice: Pulsed dye laserhttps://ClinicalTrials.gov/show/NCT00142441
184207184207Cetuximab in Patients With Unresectable or Metastatic Hepatocellular CarcinomaCompletedNo Results AvailableHepatocellular CarcinomaDrug: Cetuximabhttps://ClinicalTrials.gov/show/NCT00142428
184208184208Study of Lutetium-177 Labeled cG250 in Patients With Advanced Renal CancerCompletedNo Results AvailableMetastatic Renal Cell CarcinomaDrug: 111-In-DOTA-cG250|Drug: 177-Lu-DOTA-cG250https://ClinicalTrials.gov/show/NCT00142415
184209184209Modafinil in Multiple SclerosisCompletedNo Results AvailableMultiple SclerosisDrug: Modafinilhttps://ClinicalTrials.gov/show/NCT00142402
184210184210Mother's Gift ProjectCompletedNo Results AvailablePneumococcal InfectionsBiological: pneumococcal polysaccharide and protein conjugate vaccineshttps://ClinicalTrials.gov/show/NCT00142389
184211184211Short Term Outcomes of Children With Acute Respiratory Distress SyndromeCompletedNo Results AvailableAcute Respiratory Distress Syndromehttps://ClinicalTrials.gov/show/NCT00142376
184212184212Cohorts and Collections: Clinical and Genetic Study of Parkinson's Disease and EpilepsiesTerminatedNo Results AvailableParkinson's Disease|Epilepsyhttps://ClinicalTrials.gov/show/NCT00142363
184213184213A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric CancerCompletedNo Results AvailableGastric CancerDrug: continuous infusion of 5-fluorouracil|Drug: combination of irinotecan and cisplatin|Drug: oral administration of S-1https://ClinicalTrials.gov/show/NCT00142350
184214184214One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose NevirapineCompletedNo Results AvailableHIV InfectionsDrug: Zidovudine (ZDV)|Drug: Didanosine (ddI)https://ClinicalTrials.gov/show/NCT00142337
184215184215CALM-ADActive, not recruitingNo Results AvailableAlzheimer's DiseaseDrug: Donepezilhttps://ClinicalTrials.gov/show/NCT00142324
184216184216Functional Characterization of Parkin + PatientsTerminatedNo Results AvailableParkinson's Diseasehttps://ClinicalTrials.gov/show/NCT00142311
184217184217Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine StudiesCompletedHas ResultsChronic Hepatitis BDrug: Telbivudine (LdT)https://ClinicalTrials.gov/show/NCT00142298
184218184218Zinc Pneumonia Outpatient Trial in Children - CompletedNo Results AvailablePneumoniaDrug: Zinc sulphate (20 mg)https://ClinicalTrials.gov/show/NCT00142285
184219184219Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical TrialCompletedNo Results AvailableCholeraDrug: Ciprofloxacinhttps://ClinicalTrials.gov/show/NCT00142272
184220184220Efficacy and Safety of DBS of the GPi in Patients With Primary Generalized and Segmental DystoniaActive, not recruitingNo Results AvailableDystoniaDevice: Deep brain stimulation of the internal globus pallidushttps://ClinicalTrials.gov/show/NCT00142259
184221184221Study of the Impact of Intermittent Preventive Treatment in Schools on Malaria, Anaemia and Education.CompletedNo Results AvailableMalaria, FalciparumDrug: Intermittent preventive treatment (SP and amodiaquine)|Other: Placebohttps://ClinicalTrials.gov/show/NCT00142246
184222184222EUROPAC-2 - Pain Treatment of Hereditary and Idiopathic PancreatitisRecruitingNo Results AvailablePancreatitisDrug: Magnesium (15 mmol/d)|Drug: ANTOX (vers.) 1.2 (300 µg organic selenium, 54000 IU beta carotene, 750 mg vitamin C, 540 IU vitamin E, 2700 mg methionine)https://ClinicalTrials.gov/show/NCT00142233
184223184223The Benefit of Adding Fish Oil to the Nutrition of Critically Ill PatientsCompletedNo Results AvailableSepsis SyndromeDrug: Defined percentage of omega-3-fatty acidshttps://ClinicalTrials.gov/show/NCT00142220
184224184224Preventing Malaria During Pregnancy in Epidemic-Prone Areas.CompletedNo Results AvailableMalaria, FalciparumDrug: Intermittent preventive treatment:sulphadoxine-pyrimethamine|Device: Insecticide-treated mosquito bed nethttps://ClinicalTrials.gov/show/NCT00142207
184225184225Markers of Oxidative Stress Present in Blood in Patients With Atrial FibrillationCompletedNo Results AvailableAtrial Fibrillation|Inflammation|Atrial Flutterhttps://ClinicalTrials.gov/show/NCT00142194
184226184226Phase II Study of Campath-1H Antibody to Treat Waldenstrom's MacroglobulinemiaCompletedNo Results AvailableLymphoplasmacytic Lymphoma|Waldenstrom's MacroglobulinemiaDrug: Campath-1Hhttps://ClinicalTrials.gov/show/NCT00142181
184227184227CC-5013 and Rituximab in Waldenstrom's MacroglobulinemiaCompletedNo Results AvailableWaldenstrom's MacroglobulinemiaDrug: CC-5103|Drug: Rituximabhttps://ClinicalTrials.gov/show/NCT00142168
184228184228Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's MacroglobulinemiaCompletedNo Results AvailableWaldenstrom's MacroglobulinemiaDrug: Rituximab|Drug: monoclonal antibodieshttps://ClinicalTrials.gov/show/NCT00142155
184229184229Bortezomib (Velcade) in Waldenstrom's MacroglobulinemiaCompletedNo Results AvailableWaldenstrom's Macroglobulinemia|Lymphoplasmacytic LymphomaDrug: Bortezomib (Velcade)https://ClinicalTrials.gov/show/NCT00142129
184230184230Thalidomide and Rituximab in Waldenstrom's MacroglobulinemiaCompletedHas ResultsWaldenstrom's Macroglobulinemia|Lymphoplasmacytic LymphomaDrug: Thalidomide|Drug: Rituximabhttps://ClinicalTrials.gov/show/NCT00142116

* Görseller ve İçerik tekif hakkına sahip olabilir